Opioid Use Disorder Clinical Trials in Columbus, Ohio

4 studies are recruiting for opioid use disorder in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness

    Homelessness severely affects health and well-being and is particularly negative for youth. Between 70-95% of youth experiencing homelessness (YEH) report problem substance use and 66-89% have a mental health disorder. Youth appear to be at greater risk for living on the streets or being homeless t…

    Stage
    Not phased
    Ages
    14 to 24
    Site
    Star House, Columbus, Ohio
    Locations
    2 in total
    Run by
    Ohio State University
  2. A Study of Brenipatide in Participants With Opioid Use Disorder

    The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Ohio Clinical Trials, Columbus, Ohio
    Locations
    59 in total
    Run by
    Eli Lilly and Company
  3. Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD

    The goal of this clinical trial is to reduce heavy drinking and enhance medication for opioid use disorder (MOUD) outcomes in individuals receiving MOUD. The main questions it aims to answer are: * Does the brief, digitally-enhanced, virtual psychotherapeutic intervention, called Managing Physical …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Ohio State University, Columbus, Ohio
    Run by
    Ohio State University
  4. Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

    The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.

    Stage
    Not phased
    Ages
    18 to 50
    Site
    Battelle Memorial Institute, Columbus, Ohio
    Locations
    2 in total
    Run by
    Spark Biomedical, Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.